arGEN-X completes venture financing

arGEN-X B.V., Rotterdam, the Netherlands Business: Antibodies Date completed: 12/1/11 Type: Venture financing Raised: €27.5 million ($36.7 million) Investors: OrbiMed Advisors; Seventure Partners; For...